The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation.
نویسندگان
چکیده
The binding of 14C-labeled tranexamic acid (trunsAMCHA, transamin) to native (NH2 terminus Glu) and proteolytically modified (NH2 terminus Lys) human plasminogen was studied by an ultrafiltration technique, as was done earlier for the binding of e-aminocaproic acid to the same zymogen forms. Binding was determined at total ligand concentrations ranging from 5 pM to 16 mu, at pH 8, and 20°C. The binding constants were determined by a computer program using nonlinear least squares fitting techniques. In native plasminogen, tranexamic acid has a single strong binding site (&iss = 1.1 PM) and a group of about 4 weak sites (&ss = 0.75 I’fIM). In modified plasminogen, the first site is weaker than in the native one (Kdiss = 2.2 PM), but the second site is considerably stronger (Kdiss = 36 PM) than the corresponding one in the native protein. The remaining 2 to 3 sites in the modified zymogen bind tranexamic acid weakly (Kdiss = 1 mu). The conformational transition, known to accompany binding of this ligand to the native protein, was studied by sedimentation velocity measurements. A midpoint of 0.78 mu tranexamic acid was obtained for the effect, corresponding to the saturation of the weak set of sites, as was found earlier for l -aminocaproic acid binding. A much smaller change in sedimentation coefficient was also observed upon saturation of the modified zymogen. Correlation of binding and sedimentation data with rates of urokinase activation of the two proteins indicated that the strong binding of the first ligand molecule causes little change in the conformation of the protein and inhibits the activation rate only slightly. Saturation of the weak sites, however, is responsible for most of the conformational change and also for the large increase in activation rate of the native zymogen. Comparison of the binding constants, obtained in this study at homologous binding regions in the two proteins, permitted the calculation of free energy changes involved in the conformational transition in each of these binding regions.
منابع مشابه
Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Active-site-inhibited plasmin was prepared by inhibition with d-valyl-l-phenylalanyl-l-lysylchloromethane or by bovine pancreatic trypsin inhibitor (Kunitz inhibitor). Active-site-inhibited Glu-plasmin binds far more strongly to fibrin than Glu-plasminogen [native human plasminogen with N-terminal glutamic acid (residues 1-790)]. This binding is decreased by alpha(2)-plasmin inhibitor and trane...
متن کاملBinding of Lys-plasminogen to monocytes/macrophages.
The ability of mononuclear phagocytes to assemble and activate components of the fibrinolytic system on their surfaces may be crucial in effecting an efficient inflammatory response. Lys-plasminogen, the plasmin modified form of this zymogen, was found to bind specifically and with high affinity to murine peritoneal macrophages and to cells of the human monocytoid line U937. This modified plasm...
متن کاملEndothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.
Lysine-plasminogen (Lys-PLG), the plasmin-modified form of native glutamic acid-plasminogen (Glu-PLG), displays enhanced binding affinity for fibrin and also enhanced activation by urokinase and tissue plasminogen activator. We previously demonstrated high-affinity, specific, and functional binding of Glu-PLG as well as tissue plasminogen activator to cultured human umbilical vein endothelial c...
متن کاملاثر آنتی بادی های منوکلونال ضد پلاسمینوژن انسانی بر فعال شدن گلو-پلاسمینوژن انسانی بوسیله فعال کننده های پلاسمینوژن
Background: Human plasminogen is a plasma glycoprotein synthesized mainly in the liver. Conversion of plasminogen to plasmin by plasminogen activators is a key event in the fibrinolytic system. In this study, we investigated the effects of two anti-human plasminogen monoclonal antibodies, A1D12 and MC2B8 on Glu-plasminogen activation in presence of u-PA, t-PA and streptokinase. Methods: Produci...
متن کاملLys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.
Plasminogen, the zymogen form of the fibrinolytic enzyme plasmin, is known to undergo plasmin-mediated modification in vitro. The modified form, Lys-plasminogen, is superior to the native Glu-plasminogen in fibrin binding and as a substrate for activation by tissue-type plasminogen activator (t-PA). The present study was undertaken to determine the existence and significance of the Glu- to Lys-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of biological chemistry
دوره 254 4 شماره
صفحات -
تاریخ انتشار 1979